Rare uterine tumors with pregnancy-like features linked to poor survival
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Dec-2025 12:11 ET (20-Dec-2025 17:11 GMT/UTC)
Sutter Health researchers at California Pacific Medical Center have identified a promising new drug combination that may help patients with advanced melanoma whose cancer no longer responds to immunotherapy. In preclinical models, the regimen both shrank tumors and reactivated the immune system, offering hope for new treatment strategies. A clinical trial testing this approach is expected to begin at Sutter by late 2025.
To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes in the body is the first step toward alleviating human suffering. It’s also often the most difficult and costly. But an artificial intelligence (AI) breakthrough by Virginia Tech computer scientists published Sept. 16 in Cell Systems — a high-impact journal dedicated to biological research — is bringing those fog-bound processes into focus.